Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1438 results
CliniWorks, Pfizer to develop population health management platform
CliniWorks has announced a strategic alliance between its I subsidiary CliniWorks (Israel) (CliniWorks Israel) and Pfizer to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health.
Automation > IT & Software > News
Orgenesis, MaSTherCell to scale manufacturing of insulin-producing liver cells
By PBR Staff Writer
Orgenesis SPRL, Belgian subsidiary of US-based Orgenesis (ORGS), has signed a strategic agreement with MaSTherCell of Gosselies, Belgium, to scale manufacturing of insulin-producing liver cells to combat diabetes.
Automation > IT & Software > News
Collegium gets US patent covering Oxycodone DETERx
Collegium Pharmaceutical, a specialty pharmaceutical company, has announced that U.S. Patent No. 8,758,813 has been issued by the U.S. Patent and Trademark Office (USPTO).
Automation > IT & Software > News
Quintiles acquires Encore Health Resources
By PBR Staff Writer
Quintiles, a US-based biopharmaceutical development and commercial outsourcing services firm, has completed the acquisition of Encore Health Resources (Encore), a provider of health-information analytics and technology consulting services industry focused on healthcare providers.
Automation > IT & Software > News
CureVac, Sanofi Pasteur ink license deal for mRNA-based prophylactic vaccine
By PBR Staff Writer
German-based biopharmaceutical firm CureVac has signed an exclusive license agreement with Sanofi Pasteur, the vaccines division of Sanofi, for the development and commercialization of an mRNA-based vaccine against an undisclosed pathogen.
Automation > IT & Software > News
Icon Bioscience closes patient enrollment in Phase III trial of IBI-10090
By PBR Staff Writer
US-based biopharmaceutical firm Icon Bioscience has completed patient enrollment in its pivotal phase III trial of its lead pipeline product IBI-10090, about four months ahead of projected timelines.
Automation > IT & Software > News
Roche invests in Stratos Genomics to further develop sequencing by expansion method
Roche has announced that it made a strategic investment in Stratos Genomics and entered into a research collaboration to support further development of their unique chemistry applied to single molecule sequencing of DNA fragments using protein nanopores.
Automation > IT & Software > News
OmniComm signs multi-year agreement with top CROs for TrialOne
OmniComm Systems, a global provider of clinical data management solutions for clinical trials, has announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.
Automation > IT & Software > News
Cook Pharmica, Selexis establish biologic drug development platform
Cook Pharmica, a leading biopharmaceutical contract development and manufacturing organization (CDMO), and Selexis, a serial innovation company focused on biologic drug discovery and mammalian cell line development, have built a platform program to offer biopharmaceutical clients an integrated development and manufacturing solution for biologic drugs.
Automation > IT & Software > News
Inform Genomics enters into strategic collaboration with Translational Drug Development
Inform Genomics, a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine products, and Translational Drug Development LLC (TD2) based in Scottsdale, Arizona, have announced a strategic collaboration leveraging Inform Genomics' proprietary technology platform and analytic capabilities to biopharmaceutical companies through TD2's oncology drug development services.
Automation > IT & Software > News
Cara Therapeutics doses first patient in Phase Ia/Ib trial of CR845 to treat acute, chronic pain
Enteris BioPharma, an industry leader in innovative oral dosage formulations, has announced that its development partner, Cara Therapeutics (CARA) has dosed the first subjects in a further Phase 1a/1b clinical trial of a tablet formulation of its peripherally-selective kappa opioid agonist, CR845, for the treatment of acute and chronic pain.
Automation > IT & Software > News
TriLink gets patents for new ligation technology in US, Europe and New Zealand
TriLink BioTechnologies (TriLink), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, has announced that it has been awarded patents in the US (8,728,725), Europe (EP 2451980) and New Zealand (597535) for their novel ligation technology.
Automation > IT & Software > News
American CryoStem, nanoRANCH to create new cancer treatment delivery methods
By PBR Staff Writer
US-based American CryoStem has entered into initial agreements with the nanoRANCH Division of UHV Technologies (nanoRANCH) to develop new methods for the delivery of therapeutics and drugs focused upon cancer treatments using adipose derived adult stem cells.
Automation > IT & Software > News
Cubist selects Trial Interactive Platform as eTMF solution
By PBR Staff Writer
TransPerfect, a US-based provider of e-clinical solutions and language services to the life sciences industry, has announced that Cubist has selected its Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs.
Automation > IT & Software > News
VistaGen gets notice of allowance for Canadian patent expanding stem cell technology platform
VistaGen Therapeutics, a biotechnology company applying pluripotent stem cell technology for drug rescue and regenerative medicine, has announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for Canadian patent No. 2,684,022, entitled "Mesoderm and Definitive Endoderm Cell Populations."
Automation > IT & Software > News
91-105 of 1438 results